Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying the side effects and how well giving alvocidib together with
cytarabine and mitoxantrone works in treating patients with newly diagnosed acute myeloid
leukemia. Drugs used in chemotherapy, such as alvocidib, cytarabine, and mitoxantrone, work
in different ways to stop the growth of cancer cells, either by killing the cells or by
stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill
more cancer cells.